Table 9 Treatment group designations and treatments by period.

From: Robenacoxib shows efficacy for the treatment of chronic degenerative joint disease-associated pain in cats: a randomized and blinded pilot clinical trial

Group and treatment sequence

2-week baseline period (non-blinded)

3-week treatment period 1 (T1a)

3-week treatment period 2 (T2a)

1 (PP)

Placebo

Placebo

Placebo

2 (RR)

Placebo

Robenacoxib

Robenacoxib

3 (RP)

Placebo

Robenacoxib

Placebo

  1. P placebo, R robenacoxib.
  2. aTreatment periods T1 and T2 were blinded.
Back to article page